Searched for
MODERNA PFIZER VACCINE
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents rel...- Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts sayModerna, the COVID-19 vaccine manufacturer, is poised to meet its 2023 sales target as it taps into the private market. Analysts suggest th...
- Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccineModerna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...
- Moderna's COVID vaccine is effective in children under 6, FDA saysThe FDA cautioned that estimates of the efficacy of Moderna's two-dose pediatric vaccine were based on relatively few cases of COVID-19. Th...
- Moderna COVID-19 shot more likely to cause heart inflammation than Pfizer's, study showsModerna's COVID-19 vaccine is up to four times more likely to cause inflammation of the heart muscle, a very rare side effect, than its riv...
- Moderna finds that inventing a COVID-19 vaccine was the easy partModerna shares plummeted on Thursday after it announced it would be able to supply only 700 million to 800 million vaccine doses this year,...
- Moderna says its COVID-19 vaccine protective, safe in young childrenModerna Inc said on Monday that its COVID-19 vaccine generated an immune response and was generally well-tolerated in children aged six to ...
- Moderna's single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 crore doses for 2021Two rounds of high-level meetings chaired by the Cabinet Secretary were held last week on the availability of vaccines in the global as wel...
- Vaccination halted at all 400 sites for 18-44 age group in Delhi: Manish SisodiaSisodia said all the 400 vaccination sites for the 18-44 age group have been closed in Delhi after the vaccine stock was over, while the ce...
- Moderna raises 2021 sales forecast for COVID-19 vaccine to $19.2 billionEarlier this week, larger rival Pfizer Inc said it expects $26 billion in sales of its COVID-19 vaccine this year.
- Johnson & Johnson asked rival COVID-19 vaccine makers to probe clotting risks: WSJAstraZeneca, which had been buffeted by similar blood-clotting concerns for weeks, agreed, while Pfizer Inc and Moderna executive declined,...
- EU agency ponders approval for Moderna's COVID-19 vaccineThe meeting of the European Medicines Agency's human medicines committee (CHMP) comes amid high rates of infections in many EU countries an...
- Moderna's COVID-19 vaccine shots leave warehouses, widening America's push to immunizeThe distribution of Moderna's vaccine to more than 3,700 locations in the United States will vastly widen the rollout started last week by ...
- Moderna COVID-19 vaccine begins rollout as U.S. races to broaden injection campaignThe Food and Drug Administration on Friday approved an emergency use authorization for Moderna's vaccine, the second COVID-19 vaccine to re...
- Canada has deal to get Moderna COVID-19 vaccine within 48 hours of approvalModerna's vaccine is currently under review by Canada's drug regulator. The Pfizer/BioNTech vaccine received regulatory approval last week ...
- Moderna's COVID-19 vaccine clears first US FDA hurdleFDA staff said a two-dose regimen of Moderna's vaccine was highly effective in preventing confirmed cases of COVID-19. The comments were ma...
- Price of our Covid vaccine lower than Pfizer and Moderna's: Sputnik V Twitter account"Translating pharma lingo: the announced price of Pfizer of USD 19.50 and Moderna of USD 25-USD 37 per dose actually means their price of U...
- India's likely to get access to Moderna's coronavirus vaccine via COVAX facilitySince Moderna received funding from the Coalition for Epidemic Preparedness Innovations (CEPI), which is a part of COVAX, India may get dos...
- Moderna, Pfizer shots look strong. Here’s how they stack upThe data will likely increase confidence that more vaccines will work and that the world may soon find a way to get the coronavirus under c...
- EU says more vaccine deals to come soon as Moderna unveils positive resultsOn Aug. 24 the EU Commission, which conducts talks with vaccine makers on behalf of EU states, said exploratory talks with Moderna had been...
Load More
